Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia Matassova

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Drug Discovery Today|October 24, 2006
Towards the discovery of drug-like RNA ligands?Nicolas Foloppe, Natalia Matassova, Fareed Aboul-Ela
Journal of Medicinal Chemistry|February 14, 2014
Off-rate screening (ORS) by surface plasmon resonance. An efficient method to kinetically sample hit to lead chemical space from unpurified reaction productsJames B Murray, Stephen D Roughley, Natalia Matassova, et al.
Chemistry & Biology|September 5, 2003
Structural basis for contrasting activities of ribosome binding thiazole antibioticsGeorg Lentzen, Roscoe Klinck, Natalia Matassova, et al.
Progress in Medicinal Chemistry|January 23, 2003
RNA as a drug targetMartin J Drysdale, Georg Lentzen, Natalia Matassova, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
Structure-based design of agents targeting the bacterial ribosomeJustin Bower, Martin Drysdale, Richard Hebdon, et al.
Nature Chemistry|February 22, 2017
Dynamic undocking and the quasi-bound state as tools for drug discoverySergio Ruiz-Carmona, Peter Schmidtke, F Javier Luque, et al.
Analytical Chemistry|June 29, 2013
Fragment screening by weak affinity chromatography: comparison with established techniques for screening against HSP90Elinor Meiby, Heather Simmonite, Loic le Strat, et al.
Communications Chemistry|January 27, 2023
Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixturesLisa M Baker, Anthony Aimon, James B Murray, et al.
Oncotarget|November 19, 2014
VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cellsJonathan D Moore, Anna Staniszewska, Terence Shaw, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2009
Structure-guided design of alpha-amino acid-derived Pin1 inhibitorsAndrew J Potter, Stuart Ray, Louisa Gueritz, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|October 24, 2006
Towards the discovery of drug-like RNA ligands?Nicolas Foloppe, Natalia Matassova, Fareed Aboul-Ela
Journal of Medicinal Chemistry|February 14, 2014
Off-rate screening (ORS) by surface plasmon resonance. An efficient method to kinetically sample hit to lead chemical space from unpurified reaction productsJames B Murray, Stephen D Roughley, Natalia Matassova, et al.
Chemistry & Biology|September 5, 2003
Structural basis for contrasting activities of ribosome binding thiazole antibioticsGeorg Lentzen, Roscoe Klinck, Natalia Matassova, et al.
Progress in Medicinal Chemistry|January 23, 2003
RNA as a drug targetMartin J Drysdale, Georg Lentzen, Natalia Matassova, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2003
Structure-based design of agents targeting the bacterial ribosomeJustin Bower, Martin Drysdale, Richard Hebdon, et al.
Nature Chemistry|February 22, 2017
Dynamic undocking and the quasi-bound state as tools for drug discoverySergio Ruiz-Carmona, Peter Schmidtke, F Javier Luque, et al.
Analytical Chemistry|June 29, 2013
Fragment screening by weak affinity chromatography: comparison with established techniques for screening against HSP90Elinor Meiby, Heather Simmonite, Loic le Strat, et al.
Communications Chemistry|January 27, 2023
Rapid optimisation of fragments and hits to lead compounds from screening of crude reaction mixturesLisa M Baker, Anthony Aimon, James B Murray, et al.
Oncotarget|November 19, 2014
VER-246608, a novel pan-isoform ATP competitive inhibitor of pyruvate dehydrogenase kinase, disrupts Warburg metabolism and induces context-dependent cytostasis in cancer cellsJonathan D Moore, Anna Staniszewska, Terence Shaw, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2009
Structure-guided design of alpha-amino acid-derived Pin1 inhibitorsAndrew J Potter, Stuart Ray, Louisa Gueritz, et al.
Pageof 2